Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Drug development

First-in-class drug for sepsis and acute respiratory distress syndrome on the horizon

Researchers at Queen’s University in Belfast are developing a new anti-inflammatory drug that could help treat sepsis and acute respiratory syndrome 

Professor Chris Scott from Queen’s School of Pharmacy

Source: Courtesy of Queen’s university, Belfast

Chris Scott from Queen’s University, Belfast, School of Pharmacy

Sepsis is a leading cause of death in hospitalised patients, yet there is no effective treatment. Around 25% of patients with severe sepsis develop acute respiratory distress syndrome (ARDS), driven by an excessive immune response, and up to 30% of these patients will die.

However, a promising new anti-inflammatory drug, SAN101, is described in Science Translational Medicine (online, 2 September 2015)[1]. It is a nanoparticle that targets sialic acid-binding immunoglobulin-like lectins (siglecs) – important negative regulators of acute inflammatory responses.

SAN101 was “therapeutically beneficial” in a mouse model of sepsis and ARDS. Furthermore, it had an anti-inflammatory effect on human macrophages and relieved symptoms of acute lung injury in an ex vivo lung perfusion model. “We are well on the road to developing a new first-in-class treatment,” says Chris Scott, senior author, from Queen’s University Belfast.


Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069327

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Professor Chris Scott from Queen’s School of Pharmacy

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.